Coeliac Disease Trial, Recruiting NCT07128966 Sponsor: Joined Bio Condition: Coeliac Disease
Back to Coeliac Disease

Coeliac Disease Trial, Recruiting

NCT07128966
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are an adult, which in most US states means aged 18 to 90 (aged 19–90 if you live in Alabama or Nebraska; aged 21–90 if you live in Mississippi or Puerto Rico).
  • You have read and signed a consent form agreeing to take part in the study, or if you have difficulty making decisions, a legally authorised representative has signed on your behalf.
  • You are willing to follow all study procedures and are available for the full length of the study.
  • You meet the specific requirements of the current research request, such as having a previously diagnosed medical condition of interest or certain test results within a particular range (confirm with trial site for exact details).
  • Pregnant women may be eligible to take part in this study.

Who may not be able to join:

  • You do not meet one or more of the inclusion criteria listed above.
  • You are currently a prisoner or are under 18 years of age (or the relevant age of majority in your state).
  • Providing the requested samples, data, or feedback would put you at personal risk.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Chris Ianelli, MD, Joined Bio

Phone: 12567970003

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Joined Bio
Registry
ClinicalTrials.gov
Start date
1 April 2025
Est. completion
1 September 2035

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Observation for biomarker identification

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov